nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP3A4—Everolimus—kidney cancer	0.0807	0.185	CbGbCtD
Bromazepam—CYP1A2—Pazopanib—kidney cancer	0.0547	0.126	CbGbCtD
Bromazepam—CYP3A4—Temsirolimus—kidney cancer	0.0545	0.125	CbGbCtD
Bromazepam—CYP1A2—Erlotinib—kidney cancer	0.039	0.0896	CbGbCtD
Bromazepam—CYP2C19—Sorafenib—kidney cancer	0.0344	0.0789	CbGbCtD
Bromazepam—CYP1A2—Sorafenib—kidney cancer	0.0317	0.0728	CbGbCtD
Bromazepam—CYP3A4—Pazopanib—kidney cancer	0.0287	0.0658	CbGbCtD
Bromazepam—CYP3A4—Erlotinib—kidney cancer	0.0204	0.0469	CbGbCtD
Bromazepam—CYP3A4—Paclitaxel—kidney cancer	0.0187	0.043	CbGbCtD
Bromazepam—CYP3A4—Sorafenib—kidney cancer	0.0166	0.0382	CbGbCtD
Bromazepam—CYP3A4—Vinblastine—kidney cancer	0.0164	0.0377	CbGbCtD
Bromazepam—CYP3A4—Vincristine—kidney cancer	0.0161	0.037	CbGbCtD
Bromazepam—CYP3A4—Sunitinib—kidney cancer	0.0135	0.0309	CbGbCtD
Bromazepam—CYP3A4—Doxorubicin—kidney cancer	0.0101	0.0232	CbGbCtD
Bromazepam—Connective tissue disorder—Gemcitabine—kidney cancer	0.00112	0.00254	CcSEcCtD
Bromazepam—Cardiac disorder—Vincristine—kidney cancer	0.00111	0.00253	CcSEcCtD
Bromazepam—Anorexia—Erlotinib—kidney cancer	0.00111	0.00252	CcSEcCtD
Bromazepam—Asthenia—Pazopanib—kidney cancer	0.0011	0.00249	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00109	0.00247	CcSEcCtD
Bromazepam—Pruritus—Pazopanib—kidney cancer	0.00108	0.00246	CcSEcCtD
Bromazepam—Irritability—Capecitabine—kidney cancer	0.00108	0.00245	CcSEcCtD
Bromazepam—Cardiac arrest—Capecitabine—kidney cancer	0.00108	0.00244	CcSEcCtD
Bromazepam—Somnolence—Everolimus—kidney cancer	0.00107	0.00244	CcSEcCtD
Bromazepam—Dizziness—Temsirolimus—kidney cancer	0.00107	0.00244	CcSEcCtD
Bromazepam—Convulsion—Sunitinib—kidney cancer	0.00107	0.00243	CcSEcCtD
Bromazepam—Dry mouth—Sorafenib—kidney cancer	0.00107	0.00243	CcSEcCtD
Bromazepam—Ataxia—Capecitabine—kidney cancer	0.00106	0.00242	CcSEcCtD
Bromazepam—Dyspepsia—Everolimus—kidney cancer	0.00106	0.00241	CcSEcCtD
Bromazepam—Cardiac disorder—Gemcitabine—kidney cancer	0.00106	0.0024	CcSEcCtD
Bromazepam—Decreased appetite—Vinblastine—kidney cancer	0.00105	0.00239	CcSEcCtD
Bromazepam—Mental disorder—Vincristine—kidney cancer	0.00105	0.00239	CcSEcCtD
Bromazepam—Decreased appetite—Everolimus—kidney cancer	0.00105	0.00238	CcSEcCtD
Bromazepam—Anaphylactic shock—Sorafenib—kidney cancer	0.00105	0.00238	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00105	0.00237	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Everolimus—kidney cancer	0.00104	0.00237	CcSEcCtD
Bromazepam—Fatigue—Everolimus—kidney cancer	0.00104	0.00236	CcSEcCtD
Bromazepam—Vomiting—Temsirolimus—kidney cancer	0.00103	0.00234	CcSEcCtD
Bromazepam—Dry mouth—Sunitinib—kidney cancer	0.00103	0.00234	CcSEcCtD
Bromazepam—Nervous system disorder—Sorafenib—kidney cancer	0.00103	0.00233	CcSEcCtD
Bromazepam—Dyspepsia—Erlotinib—kidney cancer	0.00103	0.00233	CcSEcCtD
Bromazepam—Rash—Temsirolimus—kidney cancer	0.00102	0.00232	CcSEcCtD
Bromazepam—Dermatitis—Temsirolimus—kidney cancer	0.00102	0.00232	CcSEcCtD
Bromazepam—Skin disorder—Sorafenib—kidney cancer	0.00102	0.00231	CcSEcCtD
Bromazepam—Headache—Temsirolimus—kidney cancer	0.00102	0.00231	CcSEcCtD
Bromazepam—Decreased appetite—Erlotinib—kidney cancer	0.00101	0.0023	CcSEcCtD
Bromazepam—Dizziness—Pazopanib—kidney cancer	0.00101	0.0023	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00101	0.00228	CcSEcCtD
Bromazepam—Fatigue—Erlotinib—kidney cancer	0.001	0.00228	CcSEcCtD
Bromazepam—Anorexia—Sorafenib—kidney cancer	0.000999	0.00227	CcSEcCtD
Bromazepam—Feeling abnormal—Vinblastine—kidney cancer	0.000999	0.00227	CcSEcCtD
Bromazepam—Muscular weakness—Capecitabine—kidney cancer	0.000998	0.00227	CcSEcCtD
Bromazepam—Feeling abnormal—Everolimus—kidney cancer	0.000995	0.00226	CcSEcCtD
Bromazepam—Nervous system disorder—Sunitinib—kidney cancer	0.000989	0.00225	CcSEcCtD
Bromazepam—Skin disorder—Sunitinib—kidney cancer	0.00098	0.00222	CcSEcCtD
Bromazepam—Vomiting—Pazopanib—kidney cancer	0.000973	0.00221	CcSEcCtD
Bromazepam—Rash—Pazopanib—kidney cancer	0.000964	0.00219	CcSEcCtD
Bromazepam—Nausea—Temsirolimus—kidney cancer	0.000964	0.00219	CcSEcCtD
Bromazepam—Dermatitis—Pazopanib—kidney cancer	0.000964	0.00219	CcSEcCtD
Bromazepam—Anorexia—Sunitinib—kidney cancer	0.000962	0.00218	CcSEcCtD
Bromazepam—Agitation—Vincristine—kidney cancer	0.000961	0.00218	CcSEcCtD
Bromazepam—Headache—Pazopanib—kidney cancer	0.000958	0.00218	CcSEcCtD
Bromazepam—Connective tissue disorder—Paclitaxel—kidney cancer	0.000937	0.00213	CcSEcCtD
Bromazepam—Dyspepsia—Sorafenib—kidney cancer	0.000923	0.00209	CcSEcCtD
Bromazepam—Decreased appetite—Sorafenib—kidney cancer	0.000911	0.00207	CcSEcCtD
Bromazepam—Anorexia—Dactinomycin—kidney cancer	0.00091	0.00207	CcSEcCtD
Bromazepam—Nausea—Pazopanib—kidney cancer	0.000909	0.00206	CcSEcCtD
Bromazepam—Convulsion—Vincristine—kidney cancer	0.000906	0.00206	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000905	0.00205	CcSEcCtD
Bromazepam—Fatigue—Sorafenib—kidney cancer	0.000904	0.00205	CcSEcCtD
Bromazepam—Hypersensitivity—Vinblastine—kidney cancer	0.000893	0.00203	CcSEcCtD
Bromazepam—Eye disorder—Paclitaxel—kidney cancer	0.000891	0.00202	CcSEcCtD
Bromazepam—Hypersensitivity—Everolimus—kidney cancer	0.00089	0.00202	CcSEcCtD
Bromazepam—Dyspepsia—Sunitinib—kidney cancer	0.000888	0.00202	CcSEcCtD
Bromazepam—Cardiac disorder—Paclitaxel—kidney cancer	0.000885	0.00201	CcSEcCtD
Bromazepam—Decreased appetite—Sunitinib—kidney cancer	0.000877	0.00199	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000871	0.00198	CcSEcCtD
Bromazepam—Asthenia—Vinblastine—kidney cancer	0.00087	0.00197	CcSEcCtD
Bromazepam—Fatigue—Sunitinib—kidney cancer	0.00087	0.00197	CcSEcCtD
Bromazepam—Asthenia—Everolimus—kidney cancer	0.000867	0.00197	CcSEcCtD
Bromazepam—Pruritus—Everolimus—kidney cancer	0.000854	0.00194	CcSEcCtD
Bromazepam—Anaphylactic shock—Vincristine—kidney cancer	0.000853	0.00194	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000839	0.0019	CcSEcCtD
Bromazepam—Nervous system disorder—Vincristine—kidney cancer	0.000837	0.0019	CcSEcCtD
Bromazepam—Asthenia—Erlotinib—kidney cancer	0.000836	0.0019	CcSEcCtD
Bromazepam—Mental disorder—Paclitaxel—kidney cancer	0.000836	0.0019	CcSEcCtD
Bromazepam—Malnutrition—Paclitaxel—kidney cancer	0.00083	0.00188	CcSEcCtD
Bromazepam—Decreased appetite—Dactinomycin—kidney cancer	0.00083	0.00188	CcSEcCtD
Bromazepam—Pruritus—Erlotinib—kidney cancer	0.000824	0.00187	CcSEcCtD
Bromazepam—Fatigue—Dactinomycin—kidney cancer	0.000823	0.00187	CcSEcCtD
Bromazepam—Tension—Paclitaxel—kidney cancer	0.000815	0.00185	CcSEcCtD
Bromazepam—Anorexia—Vincristine—kidney cancer	0.000813	0.00185	CcSEcCtD
Bromazepam—Anaphylactic shock—Gemcitabine—kidney cancer	0.000809	0.00184	CcSEcCtD
Bromazepam—Nervousness—Paclitaxel—kidney cancer	0.000807	0.00183	CcSEcCtD
Bromazepam—Dizziness—Vinblastine—kidney cancer	0.000802	0.00182	CcSEcCtD
Bromazepam—Dizziness—Everolimus—kidney cancer	0.000799	0.00181	CcSEcCtD
Bromazepam—Muscle spasms—Paclitaxel—kidney cancer	0.000798	0.00181	CcSEcCtD
Bromazepam—Hypotension—Vincristine—kidney cancer	0.000797	0.00181	CcSEcCtD
Bromazepam—Nervous system disorder—Gemcitabine—kidney cancer	0.000794	0.0018	CcSEcCtD
Bromazepam—Feeling abnormal—Dactinomycin—kidney cancer	0.000787	0.00179	CcSEcCtD
Bromazepam—Skin disorder—Gemcitabine—kidney cancer	0.000786	0.00178	CcSEcCtD
Bromazepam—Vision blurred—Paclitaxel—kidney cancer	0.000783	0.00178	CcSEcCtD
Bromazepam—Tremor—Paclitaxel—kidney cancer	0.000778	0.00177	CcSEcCtD
Bromazepam—Hypersensitivity—Sorafenib—kidney cancer	0.000772	0.00175	CcSEcCtD
Bromazepam—Anorexia—Gemcitabine—kidney cancer	0.000772	0.00175	CcSEcCtD
Bromazepam—Vomiting—Vinblastine—kidney cancer	0.000771	0.00175	CcSEcCtD
Bromazepam—Dizziness—Erlotinib—kidney cancer	0.000771	0.00175	CcSEcCtD
Bromazepam—Connective tissue disorder—Capecitabine—kidney cancer	0.000769	0.00175	CcSEcCtD
Bromazepam—Vomiting—Everolimus—kidney cancer	0.000768	0.00174	CcSEcCtD
Bromazepam—Agitation—Paclitaxel—kidney cancer	0.000763	0.00173	CcSEcCtD
Bromazepam—Rash—Everolimus—kidney cancer	0.000762	0.00173	CcSEcCtD
Bromazepam—Dermatitis—Everolimus—kidney cancer	0.000761	0.00173	CcSEcCtD
Bromazepam—Headache—Vinblastine—kidney cancer	0.00076	0.00172	CcSEcCtD
Bromazepam—Headache—Everolimus—kidney cancer	0.000757	0.00172	CcSEcCtD
Bromazepam—Hypotension—Gemcitabine—kidney cancer	0.000756	0.00172	CcSEcCtD
Bromazepam—Asthenia—Sorafenib—kidney cancer	0.000752	0.00171	CcSEcCtD
Bromazepam—Cardiac failure—Doxorubicin—kidney cancer	0.000747	0.0017	CcSEcCtD
Bromazepam—Hypersensitivity—Sunitinib—kidney cancer	0.000743	0.00169	CcSEcCtD
Bromazepam—Decreased appetite—Vincristine—kidney cancer	0.000742	0.00168	CcSEcCtD
Bromazepam—Pruritus—Sorafenib—kidney cancer	0.000742	0.00168	CcSEcCtD
Bromazepam—Vomiting—Erlotinib—kidney cancer	0.000741	0.00168	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Vincristine—kidney cancer	0.000737	0.00167	CcSEcCtD
Bromazepam—Fatigue—Vincristine—kidney cancer	0.000736	0.00167	CcSEcCtD
Bromazepam—Rash—Erlotinib—kidney cancer	0.000735	0.00167	CcSEcCtD
Bromazepam—Dermatitis—Erlotinib—kidney cancer	0.000734	0.00167	CcSEcCtD
Bromazepam—Palpitations—Paclitaxel—kidney cancer	0.000734	0.00167	CcSEcCtD
Bromazepam—Eye disorder—Capecitabine—kidney cancer	0.000732	0.00166	CcSEcCtD
Bromazepam—Headache—Erlotinib—kidney cancer	0.00073	0.00166	CcSEcCtD
Bromazepam—Diplopia—Doxorubicin—kidney cancer	0.000729	0.00166	CcSEcCtD
Bromazepam—Cardiac disorder—Capecitabine—kidney cancer	0.000727	0.00165	CcSEcCtD
Bromazepam—Asthenia—Sunitinib—kidney cancer	0.000724	0.00164	CcSEcCtD
Bromazepam—Nausea—Vinblastine—kidney cancer	0.00072	0.00163	CcSEcCtD
Bromazepam—Somnolence—Gemcitabine—kidney cancer	0.00072	0.00163	CcSEcCtD
Bromazepam—Convulsion—Paclitaxel—kidney cancer	0.000719	0.00163	CcSEcCtD
Bromazepam—Nausea—Everolimus—kidney cancer	0.000717	0.00163	CcSEcCtD
Bromazepam—Pruritus—Sunitinib—kidney cancer	0.000714	0.00162	CcSEcCtD
Bromazepam—Decreased appetite—Gemcitabine—kidney cancer	0.000704	0.0016	CcSEcCtD
Bromazepam—Hypersensitivity—Dactinomycin—kidney cancer	0.000704	0.0016	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000702	0.00159	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000699	0.00159	CcSEcCtD
Bromazepam—Fatigue—Gemcitabine—kidney cancer	0.000698	0.00158	CcSEcCtD
Bromazepam—Cardiac arrest—Doxorubicin—kidney cancer	0.000694	0.00157	CcSEcCtD
Bromazepam—Dizziness—Sorafenib—kidney cancer	0.000693	0.00157	CcSEcCtD
Bromazepam—Nausea—Erlotinib—kidney cancer	0.000692	0.00157	CcSEcCtD
Bromazepam—Dry mouth—Paclitaxel—kidney cancer	0.000691	0.00157	CcSEcCtD
Bromazepam—Ataxia—Doxorubicin—kidney cancer	0.000686	0.00156	CcSEcCtD
Bromazepam—Mental disorder—Capecitabine—kidney cancer	0.000686	0.00156	CcSEcCtD
Bromazepam—Asthenia—Dactinomycin—kidney cancer	0.000685	0.00156	CcSEcCtD
Bromazepam—Confusional state—Paclitaxel—kidney cancer	0.000683	0.00155	CcSEcCtD
Bromazepam—Malnutrition—Capecitabine—kidney cancer	0.000681	0.00155	CcSEcCtD
Bromazepam—Anaphylactic shock—Paclitaxel—kidney cancer	0.000678	0.00154	CcSEcCtD
Bromazepam—Dizziness—Sunitinib—kidney cancer	0.000667	0.00151	CcSEcCtD
Bromazepam—Feeling abnormal—Gemcitabine—kidney cancer	0.000667	0.00151	CcSEcCtD
Bromazepam—Vomiting—Sorafenib—kidney cancer	0.000667	0.00151	CcSEcCtD
Bromazepam—Nervous system disorder—Paclitaxel—kidney cancer	0.000665	0.00151	CcSEcCtD
Bromazepam—Tachycardia—Paclitaxel—kidney cancer	0.000661	0.0015	CcSEcCtD
Bromazepam—Rash—Sorafenib—kidney cancer	0.000661	0.0015	CcSEcCtD
Bromazepam—Dermatitis—Sorafenib—kidney cancer	0.00066	0.0015	CcSEcCtD
Bromazepam—Skin disorder—Paclitaxel—kidney cancer	0.000658	0.00149	CcSEcCtD
Bromazepam—Headache—Sorafenib—kidney cancer	0.000657	0.00149	CcSEcCtD
Bromazepam—Muscle spasms—Capecitabine—kidney cancer	0.000655	0.00149	CcSEcCtD
Bromazepam—Anorexia—Paclitaxel—kidney cancer	0.000646	0.00147	CcSEcCtD
Bromazepam—Muscular weakness—Doxorubicin—kidney cancer	0.000643	0.00146	CcSEcCtD
Bromazepam—Vision blurred—Capecitabine—kidney cancer	0.000642	0.00146	CcSEcCtD
Bromazepam—Vomiting—Sunitinib—kidney cancer	0.000641	0.00146	CcSEcCtD
Bromazepam—Tremor—Capecitabine—kidney cancer	0.000638	0.00145	CcSEcCtD
Bromazepam—Rash—Sunitinib—kidney cancer	0.000636	0.00144	CcSEcCtD
Bromazepam—Dermatitis—Sunitinib—kidney cancer	0.000635	0.00144	CcSEcCtD
Bromazepam—Hypotension—Paclitaxel—kidney cancer	0.000633	0.00144	CcSEcCtD
Bromazepam—Headache—Sunitinib—kidney cancer	0.000632	0.00143	CcSEcCtD
Bromazepam—Hypersensitivity—Vincristine—kidney cancer	0.000629	0.00143	CcSEcCtD
Bromazepam—Nausea—Sorafenib—kidney cancer	0.000623	0.00141	CcSEcCtD
Bromazepam—Asthenia—Vincristine—kidney cancer	0.000612	0.00139	CcSEcCtD
Bromazepam—Vomiting—Dactinomycin—kidney cancer	0.000607	0.00138	CcSEcCtD
Bromazepam—Somnolence—Paclitaxel—kidney cancer	0.000602	0.00137	CcSEcCtD
Bromazepam—Palpitations—Capecitabine—kidney cancer	0.000602	0.00137	CcSEcCtD
Bromazepam—Rash—Dactinomycin—kidney cancer	0.000602	0.00137	CcSEcCtD
Bromazepam—Nausea—Sunitinib—kidney cancer	0.000599	0.00136	CcSEcCtD
Bromazepam—Dyspepsia—Paclitaxel—kidney cancer	0.000597	0.00135	CcSEcCtD
Bromazepam—Decreased appetite—Paclitaxel—kidney cancer	0.000589	0.00134	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000585	0.00133	CcSEcCtD
Bromazepam—Fatigue—Paclitaxel—kidney cancer	0.000584	0.00133	CcSEcCtD
Bromazepam—Asthenia—Gemcitabine—kidney cancer	0.000581	0.00132	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000576	0.00131	CcSEcCtD
Bromazepam—Pruritus—Gemcitabine—kidney cancer	0.000573	0.0013	CcSEcCtD
Bromazepam—Dry mouth—Capecitabine—kidney cancer	0.000567	0.00129	CcSEcCtD
Bromazepam—Nausea—Dactinomycin—kidney cancer	0.000567	0.00129	CcSEcCtD
Bromazepam—Dizziness—Vincristine—kidney cancer	0.000564	0.00128	CcSEcCtD
Bromazepam—Drowsiness—Doxorubicin—kidney cancer	0.000562	0.00128	CcSEcCtD
Bromazepam—Confusional state—Capecitabine—kidney cancer	0.000561	0.00127	CcSEcCtD
Bromazepam—Feeling abnormal—Paclitaxel—kidney cancer	0.000558	0.00127	CcSEcCtD
Bromazepam—Nervous system disorder—Capecitabine—kidney cancer	0.000545	0.00124	CcSEcCtD
Bromazepam—Tachycardia—Capecitabine—kidney cancer	0.000543	0.00123	CcSEcCtD
Bromazepam—Vomiting—Vincristine—kidney cancer	0.000543	0.00123	CcSEcCtD
Bromazepam—Skin disorder—Capecitabine—kidney cancer	0.00054	0.00123	CcSEcCtD
Bromazepam—Rash—Vincristine—kidney cancer	0.000538	0.00122	CcSEcCtD
Bromazepam—Dermatitis—Vincristine—kidney cancer	0.000537	0.00122	CcSEcCtD
Bromazepam—Headache—Vincristine—kidney cancer	0.000535	0.00121	CcSEcCtD
Bromazepam—Anorexia—Capecitabine—kidney cancer	0.00053	0.0012	CcSEcCtD
Bromazepam—Hypotension—Capecitabine—kidney cancer	0.00052	0.00118	CcSEcCtD
Bromazepam—Vomiting—Gemcitabine—kidney cancer	0.000515	0.00117	CcSEcCtD
Bromazepam—Rash—Gemcitabine—kidney cancer	0.00051	0.00116	CcSEcCtD
Bromazepam—Dermatitis—Gemcitabine—kidney cancer	0.00051	0.00116	CcSEcCtD
Bromazepam—Headache—Gemcitabine—kidney cancer	0.000507	0.00115	CcSEcCtD
Bromazepam—Nausea—Vincristine—kidney cancer	0.000507	0.00115	CcSEcCtD
Bromazepam—Hypersensitivity—Paclitaxel—kidney cancer	0.000499	0.00113	CcSEcCtD
Bromazepam—Connective tissue disorder—Doxorubicin—kidney cancer	0.000496	0.00113	CcSEcCtD
Bromazepam—Dyspepsia—Capecitabine—kidney cancer	0.00049	0.00111	CcSEcCtD
Bromazepam—Asthenia—Paclitaxel—kidney cancer	0.000486	0.0011	CcSEcCtD
Bromazepam—Decreased appetite—Capecitabine—kidney cancer	0.000483	0.0011	CcSEcCtD
Bromazepam—Nausea—Gemcitabine—kidney cancer	0.000481	0.00109	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00048	0.00109	CcSEcCtD
Bromazepam—Fatigue—Capecitabine—kidney cancer	0.000479	0.00109	CcSEcCtD
Bromazepam—Pruritus—Paclitaxel—kidney cancer	0.000479	0.00109	CcSEcCtD
Bromazepam—Eye disorder—Doxorubicin—kidney cancer	0.000472	0.00107	CcSEcCtD
Bromazepam—Cardiac disorder—Doxorubicin—kidney cancer	0.000468	0.00106	CcSEcCtD
Bromazepam—Feeling abnormal—Capecitabine—kidney cancer	0.000458	0.00104	CcSEcCtD
Bromazepam—Dizziness—Paclitaxel—kidney cancer	0.000448	0.00102	CcSEcCtD
Bromazepam—Mental disorder—Doxorubicin—kidney cancer	0.000442	0.001	CcSEcCtD
Bromazepam—Malnutrition—Doxorubicin—kidney cancer	0.000439	0.000997	CcSEcCtD
Bromazepam—Tension—Doxorubicin—kidney cancer	0.000431	0.000978	CcSEcCtD
Bromazepam—Vomiting—Paclitaxel—kidney cancer	0.000431	0.000978	CcSEcCtD
Bromazepam—Rash—Paclitaxel—kidney cancer	0.000427	0.00097	CcSEcCtD
Bromazepam—Dermatitis—Paclitaxel—kidney cancer	0.000427	0.000969	CcSEcCtD
Bromazepam—Nervousness—Doxorubicin—kidney cancer	0.000427	0.000968	CcSEcCtD
Bromazepam—Headache—Paclitaxel—kidney cancer	0.000425	0.000964	CcSEcCtD
Bromazepam—Muscle spasms—Doxorubicin—kidney cancer	0.000422	0.000959	CcSEcCtD
Bromazepam—Vision blurred—Doxorubicin—kidney cancer	0.000414	0.00094	CcSEcCtD
Bromazepam—Hypersensitivity—Capecitabine—kidney cancer	0.00041	0.00093	CcSEcCtD
Bromazepam—Agitation—Doxorubicin—kidney cancer	0.000404	0.000916	CcSEcCtD
Bromazepam—Nausea—Paclitaxel—kidney cancer	0.000403	0.000914	CcSEcCtD
Bromazepam—Asthenia—Capecitabine—kidney cancer	0.000399	0.000906	CcSEcCtD
Bromazepam—Pruritus—Capecitabine—kidney cancer	0.000393	0.000893	CcSEcCtD
Bromazepam—Palpitations—Doxorubicin—kidney cancer	0.000388	0.000881	CcSEcCtD
Bromazepam—Convulsion—Doxorubicin—kidney cancer	0.000381	0.000864	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000371	0.000843	CcSEcCtD
Bromazepam—Dizziness—Capecitabine—kidney cancer	0.000368	0.000835	CcSEcCtD
Bromazepam—Dry mouth—Doxorubicin—kidney cancer	0.000366	0.00083	CcSEcCtD
Bromazepam—Confusional state—Doxorubicin—kidney cancer	0.000361	0.00082	CcSEcCtD
Bromazepam—Anaphylactic shock—Doxorubicin—kidney cancer	0.000358	0.000814	CcSEcCtD
Bromazepam—Vomiting—Capecitabine—kidney cancer	0.000354	0.000803	CcSEcCtD
Bromazepam—Nervous system disorder—Doxorubicin—kidney cancer	0.000352	0.000798	CcSEcCtD
Bromazepam—Rash—Capecitabine—kidney cancer	0.000351	0.000796	CcSEcCtD
Bromazepam—Dermatitis—Capecitabine—kidney cancer	0.00035	0.000795	CcSEcCtD
Bromazepam—Tachycardia—Doxorubicin—kidney cancer	0.00035	0.000794	CcSEcCtD
Bromazepam—Headache—Capecitabine—kidney cancer	0.000348	0.000791	CcSEcCtD
Bromazepam—Skin disorder—Doxorubicin—kidney cancer	0.000348	0.00079	CcSEcCtD
Bromazepam—Anorexia—Doxorubicin—kidney cancer	0.000342	0.000776	CcSEcCtD
Bromazepam—Hypotension—Doxorubicin—kidney cancer	0.000335	0.00076	CcSEcCtD
Bromazepam—Nausea—Capecitabine—kidney cancer	0.00033	0.00075	CcSEcCtD
Bromazepam—Somnolence—Doxorubicin—kidney cancer	0.000319	0.000723	CcSEcCtD
Bromazepam—Dyspepsia—Doxorubicin—kidney cancer	0.000316	0.000716	CcSEcCtD
Bromazepam—Decreased appetite—Doxorubicin—kidney cancer	0.000312	0.000707	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00031	0.000703	CcSEcCtD
Bromazepam—Fatigue—Doxorubicin—kidney cancer	0.000309	0.000702	CcSEcCtD
Bromazepam—Feeling abnormal—Doxorubicin—kidney cancer	0.000295	0.000671	CcSEcCtD
Bromazepam—Hypersensitivity—Doxorubicin—kidney cancer	0.000264	0.0006	CcSEcCtD
Bromazepam—Asthenia—Doxorubicin—kidney cancer	0.000257	0.000584	CcSEcCtD
Bromazepam—Pruritus—Doxorubicin—kidney cancer	0.000254	0.000576	CcSEcCtD
Bromazepam—Dizziness—Doxorubicin—kidney cancer	0.000237	0.000538	CcSEcCtD
Bromazepam—Vomiting—Doxorubicin—kidney cancer	0.000228	0.000517	CcSEcCtD
Bromazepam—Rash—Doxorubicin—kidney cancer	0.000226	0.000513	CcSEcCtD
Bromazepam—Dermatitis—Doxorubicin—kidney cancer	0.000226	0.000513	CcSEcCtD
Bromazepam—Headache—Doxorubicin—kidney cancer	0.000225	0.00051	CcSEcCtD
Bromazepam—Nausea—Doxorubicin—kidney cancer	0.000213	0.000483	CcSEcCtD
Bromazepam—GABRG2—Neuronal System—BRAF—kidney cancer	7.76e-05	0.000627	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—RAF1—kidney cancer	7.75e-05	0.000626	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	7.72e-05	0.000623	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—MAPK1—kidney cancer	7.68e-05	0.000621	CbGpPWpGaD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.62e-05	0.000616	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.53e-05	0.000609	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.46e-05	0.000602	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.44e-05	0.000601	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.42e-05	0.000599	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	7.39e-05	0.000597	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.36e-05	0.000595	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTM1—kidney cancer	7.35e-05	0.000594	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—MAPK1—kidney cancer	7.35e-05	0.000594	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	7.31e-05	0.00059	CbGpPWpGaD
Bromazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.26e-05	0.000586	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	7.25e-05	0.000586	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—RAF1—kidney cancer	7.08e-05	0.000572	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.06e-05	0.00057	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.02e-05	0.000567	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—MAPK1—kidney cancer	7.01e-05	0.000566	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—MAPK1—kidney cancer	7.01e-05	0.000566	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	6.97e-05	0.000563	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTT1—kidney cancer	6.94e-05	0.000561	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.93e-05	0.00056	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—RAF1—kidney cancer	6.88e-05	0.000556	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	6.88e-05	0.000555	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	6.87e-05	0.000555	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.82e-05	0.000551	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—BRAF—kidney cancer	6.78e-05	0.000548	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—RAF1—kidney cancer	6.76e-05	0.000546	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PDHB—kidney cancer	6.76e-05	0.000546	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	6.74e-05	0.000545	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—POMC—kidney cancer	6.74e-05	0.000544	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.73e-05	0.000544	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	6.72e-05	0.000543	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—RAF1—kidney cancer	6.64e-05	0.000537	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—RAF1—kidney cancer	6.6e-05	0.000533	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	6.58e-05	0.000531	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.54e-05	0.000528	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—PTGS1—kidney cancer	6.51e-05	0.000526	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—RAF1—kidney cancer	6.48e-05	0.000523	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.42e-05	0.000519	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CCBL1—kidney cancer	6.35e-05	0.000513	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.34e-05	0.000512	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.31e-05	0.00051	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.27e-05	0.000507	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTP1—kidney cancer	6.24e-05	0.000504	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	6.21e-05	0.000502	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.16e-05	0.000498	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.16e-05	0.000497	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	6.15e-05	0.000497	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ACY1—kidney cancer	6.13e-05	0.000495	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.05e-05	0.000489	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.95e-05	0.00048	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.91e-05	0.000477	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.88e-05	0.000475	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.8e-05	0.000469	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—MAPK1—kidney cancer	5.77e-05	0.000466	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.76e-05	0.000465	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTM1—kidney cancer	5.73e-05	0.000463	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—MAPK1—kidney cancer	5.69e-05	0.000459	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—RAF1—kidney cancer	5.66e-05	0.000457	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	5.65e-05	0.000456	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPAT—kidney cancer	5.51e-05	0.000445	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GLIPR1—kidney cancer	5.51e-05	0.000445	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—RAF1—kidney cancer	5.5e-05	0.000444	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—RAF1—kidney cancer	5.5e-05	0.000444	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	5.43e-05	0.000439	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.38e-05	0.000435	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—MAPK1—kidney cancer	5.38e-05	0.000435	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	5.36e-05	0.000433	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—MAPK1—kidney cancer	5.31e-05	0.000429	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.23e-05	0.000422	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PDHB—kidney cancer	5.21e-05	0.000421	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—POMC—kidney cancer	5.2e-05	0.00042	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—FH—kidney cancer	5.12e-05	0.000414	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APRT—kidney cancer	5.12e-05	0.000414	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.07e-05	0.00041	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CCBL1—kidney cancer	4.9e-05	0.000396	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—MAPK1—kidney cancer	4.86e-05	0.000392	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPC3—kidney cancer	4.82e-05	0.000389	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.81e-05	0.000389	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ACY1—kidney cancer	4.78e-05	0.000386	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.75e-05	0.000383	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—MAPK1—kidney cancer	4.72e-05	0.000381	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CA2—kidney cancer	4.68e-05	0.000378	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—MAPK1—kidney cancer	4.64e-05	0.000374	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALAD—kidney cancer	4.56e-05	0.000369	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—MAPK1—kidney cancer	4.56e-05	0.000368	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—MAPK1—kidney cancer	4.53e-05	0.000366	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	4.53e-05	0.000366	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.46e-05	0.00036	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ST3GAL2—kidney cancer	4.46e-05	0.00036	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—MAPK1—kidney cancer	4.44e-05	0.000359	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.43e-05	0.000358	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.42e-05	0.000357	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.36e-05	0.000352	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALDH1A1—kidney cancer	4.35e-05	0.000352	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPAT—kidney cancer	4.25e-05	0.000343	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GLIPR1—kidney cancer	4.25e-05	0.000343	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	4.22e-05	0.000341	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.2e-05	0.000339	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.19e-05	0.000339	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC5A3—kidney cancer	4.18e-05	0.000337	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PGK1—kidney cancer	4.18e-05	0.000337	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	4.16e-05	0.000336	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.15e-05	0.000336	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.13e-05	0.000334	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LDHB—kidney cancer	4.09e-05	0.000331	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.07e-05	0.000329	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PDHB—kidney cancer	4.06e-05	0.000328	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—POMC—kidney cancer	4.05e-05	0.000327	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—FH—kidney cancer	3.95e-05	0.000319	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APRT—kidney cancer	3.95e-05	0.000319	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—MAPK1—kidney cancer	3.88e-05	0.000314	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.86e-05	0.000312	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CCBL1—kidney cancer	3.82e-05	0.000309	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.81e-05	0.000308	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPC3—kidney cancer	3.72e-05	0.0003	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	3.7e-05	0.000299	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ACY1—kidney cancer	3.69e-05	0.000298	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.63e-05	0.000294	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CA2—kidney cancer	3.61e-05	0.000292	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.57e-05	0.000288	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CA9—kidney cancer	3.55e-05	0.000287	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.55e-05	0.000287	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALAD—kidney cancer	3.52e-05	0.000284	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.48e-05	0.000281	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.45e-05	0.000279	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ST3GAL2—kidney cancer	3.44e-05	0.000278	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALDH1A1—kidney cancer	3.36e-05	0.000271	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.31e-05	0.000268	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPAT—kidney cancer	3.31e-05	0.000268	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.27e-05	0.000264	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.24e-05	0.000261	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC5A3—kidney cancer	3.22e-05	0.00026	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PGK1—kidney cancer	3.22e-05	0.00026	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LDHB—kidney cancer	3.16e-05	0.000255	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PDHB—kidney cancer	3.14e-05	0.000253	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—POMC—kidney cancer	3.13e-05	0.000252	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—FH—kidney cancer	3.08e-05	0.000249	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APRT—kidney cancer	3.08e-05	0.000249	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.05e-05	0.000246	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CRABP1—kidney cancer	3.02e-05	0.000244	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.01e-05	0.000243	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CCBL1—kidney cancer	2.95e-05	0.000238	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPC3—kidney cancer	2.89e-05	0.000234	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CA2—kidney cancer	2.82e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ITPR2—kidney cancer	2.81e-05	0.000227	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALAD—kidney cancer	2.74e-05	0.000222	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CA9—kidney cancer	2.74e-05	0.000221	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.68e-05	0.000216	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.68e-05	0.000216	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.62e-05	0.000211	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTT1—kidney cancer	2.56e-05	0.000207	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ACHE—kidney cancer	2.56e-05	0.000207	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPAT—kidney cancer	2.56e-05	0.000206	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.56e-05	0.000206	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PGK1—kidney cancer	2.51e-05	0.000203	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.51e-05	0.000203	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LDHB—kidney cancer	2.46e-05	0.000199	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SCARB1—kidney cancer	2.42e-05	0.000196	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS1—kidney cancer	2.4e-05	0.000194	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APRT—kidney cancer	2.38e-05	0.000192	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—FH—kidney cancer	2.38e-05	0.000192	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PSMD7—kidney cancer	2.35e-05	0.00019	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CRABP1—kidney cancer	2.33e-05	0.000188	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPC3—kidney cancer	2.23e-05	0.00018	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—BCHE—kidney cancer	2.23e-05	0.00018	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC5A5—kidney cancer	2.2e-05	0.000178	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CA2—kidney cancer	2.17e-05	0.000176	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ITPR2—kidney cancer	2.17e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CA9—kidney cancer	2.13e-05	0.000172	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.13e-05	0.000172	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALAD—kidney cancer	2.12e-05	0.000171	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.09e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.07e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.02e-05	0.000163	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2e-05	0.000161	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTT1—kidney cancer	1.97e-05	0.000159	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ACHE—kidney cancer	1.97e-05	0.000159	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.94e-05	0.000156	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PGK1—kidney cancer	1.94e-05	0.000156	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LDHB—kidney cancer	1.9e-05	0.000153	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SCARB1—kidney cancer	1.87e-05	0.000151	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS1—kidney cancer	1.85e-05	0.000149	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CRABP1—kidney cancer	1.81e-05	0.000147	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PSMD7—kidney cancer	1.81e-05	0.000147	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTP1—kidney cancer	1.77e-05	0.000143	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—BCHE—kidney cancer	1.72e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.7e-05	0.000137	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ITPR2—kidney cancer	1.69e-05	0.000136	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCB1—kidney cancer	1.68e-05	0.000136	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CA9—kidney cancer	1.65e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTM1—kidney cancer	1.63e-05	0.000132	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.59e-05	0.000129	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.56e-05	0.000126	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.55e-05	0.000125	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ACHE—kidney cancer	1.54e-05	0.000124	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTT1—kidney cancer	1.54e-05	0.000124	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SCARB1—kidney cancer	1.46e-05	0.000118	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS1—kidney cancer	1.44e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PSMD7—kidney cancer	1.41e-05	0.000114	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CRABP1—kidney cancer	1.4e-05	0.000113	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.39e-05	0.000112	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTP1—kidney cancer	1.37e-05	0.000111	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—BCHE—kidney cancer	1.34e-05	0.000108	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.32e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ITPR2—kidney cancer	1.3e-05	0.000105	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCB1—kidney cancer	1.3e-05	0.000105	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.28e-05	0.000103	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTM1—kidney cancer	1.26e-05	0.000102	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.24e-05	0.0001	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.19e-05	9.63e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTT1—kidney cancer	1.19e-05	9.59e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ACHE—kidney cancer	1.19e-05	9.59e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—POMC—kidney cancer	1.15e-05	9.31e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SCARB1—kidney cancer	1.12e-05	9.08e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS1—kidney cancer	1.11e-05	8.99e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PSMD7—kidney cancer	1.09e-05	8.81e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.08e-05	8.74e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTP1—kidney cancer	1.07e-05	8.61e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—BCHE—kidney cancer	1.03e-05	8.35e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.02e-05	8.25e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCB1—kidney cancer	1.01e-05	8.15e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC2A1—kidney cancer	9.87e-06	7.97e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTM1—kidney cancer	9.8e-06	7.92e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.79e-06	7.91e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP1A1—kidney cancer	9.29e-06	7.5e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—kidney cancer	9.19e-06	7.42e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—POMC—kidney cancer	8.89e-06	7.18e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTP1—kidney cancer	8.23e-06	6.65e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTEN—kidney cancer	8.01e-06	6.47e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCB1—kidney cancer	7.79e-06	6.29e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.63e-06	6.16e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTM1—kidney cancer	7.56e-06	6.11e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP1A1—kidney cancer	7.17e-06	5.79e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—kidney cancer	7.09e-06	5.73e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—POMC—kidney cancer	6.93e-06	5.59e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTEN—kidney cancer	6.18e-06	4.99e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CA—kidney cancer	5.65e-06	4.57e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—kidney cancer	5.52e-06	4.46e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—POMC—kidney cancer	5.35e-06	4.32e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTEN—kidney cancer	4.82e-06	3.89e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CA—kidney cancer	4.36e-06	3.52e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—kidney cancer	4.26e-06	3.44e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTEN—kidney cancer	3.72e-06	3e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.4e-06	2.75e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.62e-06	2.12e-05	CbGpPWpGaD
